Monocrotaline metabolism and distribution in Fisher 344 and Sprague- Dawley rats

M. J. Reid, M. W. Lamé, O. Morin, Dennis W Wilson, H. J. Segall

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The metabolism and distribution of 14C-monocrotaline in Fisher 344 (F344) rats was compared with that in Sprague-Dawley (SD) rats. In vitro microsomal preparations, in situ isolated perfused livers and in vivo excretion and distribution studies were used to discern any differences between these two strains. These strains have previously been shown to differ in their susceptibility to monocrotaline-induced pulmonary hypertension. Hepatic phase I metabolism appears to be similar in both strains with N- oxidation and dehydrogenation to the reactive pyrroles as the major pathways. During the liver perfusions, SD rats generated more monocrotalic acid than F344 rats, but the microsome and excretion studies demonstrated no significant differences in the amount of monocrotalic acid. Monocrotalic acid is a stable byproduct of dehydromonocrotaline reacting with cellular nucleophiles and indicates the amount of monocrotaline dehydrogenation when carboxylesterase activity is negligible. These data suggest that the differences in strain susceptibility to pulmonary vascular toxicity is most likely due to differences in their response to the toxic metabolites.

Original languageEnglish (US)
Pages (from-to)115-123
Number of pages9
JournalComparative Biochemistry and Physiology - B Biochemistry and Molecular Biology
Volume117
Issue number1
DOIs
StatePublished - 1997

Fingerprint

Monocrotaline
Metabolism
Sprague Dawley Rats
Rats
Acids
Liver
Dehydrogenation
Carboxylesterase
Pyrroles
Poisons
Microsomes
Pulmonary Hypertension
Nucleophiles
Blood Vessels
Metabolites
Perfusion
Byproducts
Toxicity
Lung
Oxidation

Keywords

  • Fisher 344
  • liver perfusion
  • metabolism
  • monocrotalic acid
  • monocrotaline
  • pyrrolizidine alkaloid
  • Sprague-Dawley

ASJC Scopus subject areas

  • Biochemistry
  • Physiology

Cite this

Monocrotaline metabolism and distribution in Fisher 344 and Sprague- Dawley rats. / Reid, M. J.; Lamé, M. W.; Morin, O.; Wilson, Dennis W; Segall, H. J.

In: Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology, Vol. 117, No. 1, 1997, p. 115-123.

Research output: Contribution to journalArticle

@article{d4125b8ee19346868658293cbd58da48,
title = "Monocrotaline metabolism and distribution in Fisher 344 and Sprague- Dawley rats",
abstract = "The metabolism and distribution of 14C-monocrotaline in Fisher 344 (F344) rats was compared with that in Sprague-Dawley (SD) rats. In vitro microsomal preparations, in situ isolated perfused livers and in vivo excretion and distribution studies were used to discern any differences between these two strains. These strains have previously been shown to differ in their susceptibility to monocrotaline-induced pulmonary hypertension. Hepatic phase I metabolism appears to be similar in both strains with N- oxidation and dehydrogenation to the reactive pyrroles as the major pathways. During the liver perfusions, SD rats generated more monocrotalic acid than F344 rats, but the microsome and excretion studies demonstrated no significant differences in the amount of monocrotalic acid. Monocrotalic acid is a stable byproduct of dehydromonocrotaline reacting with cellular nucleophiles and indicates the amount of monocrotaline dehydrogenation when carboxylesterase activity is negligible. These data suggest that the differences in strain susceptibility to pulmonary vascular toxicity is most likely due to differences in their response to the toxic metabolites.",
keywords = "Fisher 344, liver perfusion, metabolism, monocrotalic acid, monocrotaline, pyrrolizidine alkaloid, Sprague-Dawley",
author = "Reid, {M. J.} and Lam{\'e}, {M. W.} and O. Morin and Wilson, {Dennis W} and Segall, {H. J.}",
year = "1997",
doi = "10.1016/S0305-0491(96)00323-9",
language = "English (US)",
volume = "117",
pages = "115--123",
journal = "Comparative biochemistry and physiology. B, Comparative biochemistry",
issn = "1096-4959",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Monocrotaline metabolism and distribution in Fisher 344 and Sprague- Dawley rats

AU - Reid, M. J.

AU - Lamé, M. W.

AU - Morin, O.

AU - Wilson, Dennis W

AU - Segall, H. J.

PY - 1997

Y1 - 1997

N2 - The metabolism and distribution of 14C-monocrotaline in Fisher 344 (F344) rats was compared with that in Sprague-Dawley (SD) rats. In vitro microsomal preparations, in situ isolated perfused livers and in vivo excretion and distribution studies were used to discern any differences between these two strains. These strains have previously been shown to differ in their susceptibility to monocrotaline-induced pulmonary hypertension. Hepatic phase I metabolism appears to be similar in both strains with N- oxidation and dehydrogenation to the reactive pyrroles as the major pathways. During the liver perfusions, SD rats generated more monocrotalic acid than F344 rats, but the microsome and excretion studies demonstrated no significant differences in the amount of monocrotalic acid. Monocrotalic acid is a stable byproduct of dehydromonocrotaline reacting with cellular nucleophiles and indicates the amount of monocrotaline dehydrogenation when carboxylesterase activity is negligible. These data suggest that the differences in strain susceptibility to pulmonary vascular toxicity is most likely due to differences in their response to the toxic metabolites.

AB - The metabolism and distribution of 14C-monocrotaline in Fisher 344 (F344) rats was compared with that in Sprague-Dawley (SD) rats. In vitro microsomal preparations, in situ isolated perfused livers and in vivo excretion and distribution studies were used to discern any differences between these two strains. These strains have previously been shown to differ in their susceptibility to monocrotaline-induced pulmonary hypertension. Hepatic phase I metabolism appears to be similar in both strains with N- oxidation and dehydrogenation to the reactive pyrroles as the major pathways. During the liver perfusions, SD rats generated more monocrotalic acid than F344 rats, but the microsome and excretion studies demonstrated no significant differences in the amount of monocrotalic acid. Monocrotalic acid is a stable byproduct of dehydromonocrotaline reacting with cellular nucleophiles and indicates the amount of monocrotaline dehydrogenation when carboxylesterase activity is negligible. These data suggest that the differences in strain susceptibility to pulmonary vascular toxicity is most likely due to differences in their response to the toxic metabolites.

KW - Fisher 344

KW - liver perfusion

KW - metabolism

KW - monocrotalic acid

KW - monocrotaline

KW - pyrrolizidine alkaloid

KW - Sprague-Dawley

UR - http://www.scopus.com/inward/record.url?scp=0030909104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030909104&partnerID=8YFLogxK

U2 - 10.1016/S0305-0491(96)00323-9

DO - 10.1016/S0305-0491(96)00323-9

M3 - Article

C2 - 9180020

AN - SCOPUS:0030909104

VL - 117

SP - 115

EP - 123

JO - Comparative biochemistry and physiology. B, Comparative biochemistry

JF - Comparative biochemistry and physiology. B, Comparative biochemistry

SN - 1096-4959

IS - 1

ER -